Martin-Jimenez Daniel, Moreno-Luna Ramon, Callejon-Leblic Amparo, Del Cuvillo Alfonso, Ebert Charles S, Maza-Solano Juan, Gonzalez-Garcia Jaime, Infante-Cossio Pedro, Sanchez-Gomez Serafin
Rhinology Unit, Department of Otolaryngology, Head and Neck Surgery, Virgen Macarena University Hospital, 41009 Seville, Spain.
Biomedical Engineering Group, University of Seville, 41004 Seville, Spain.
J Clin Med. 2024 Feb 1;13(3):866. doi: 10.3390/jcm13030866.
(1) Background: Surgical criteria for chronic rhinosinusitis with nasal polyps (CRSwNP) remain unresolved. This study addresses these discrepancies by comparing the clinical outcomes of expanded-functional endoscopic sinus surgeries (E-FESS) with more-limited FESS (L-FESS). (2) Methods: A database was analyzed retrospectively to compare surgical outcomes in CRSwNP patients who underwent E-FESS versus those subjected to L-FESS. Quality of life, endoscopic and radiological outcomes were compared at the baseline and two years after surgery. The clinical status of the responder was defined when a minimal clinically important difference of 12 points in SNOT-22 change was achieved. (3) Results: A total of 274 patients met the inclusion criteria and were analyzed; 111 underwent E-FESS and 163 were subjected to L-FESS. Both groups exhibited significant clinical improvements, although a greater magnitude of change in SNOT-22 (14.8 ± 4.8, = 0.002) was shown after E-FESS. Higher significant improvements for endoscopic and radiological scores and lower surgical revision rates were also noted in the E-FESS group. (4) Conclusions: E-FESS provides better clinical outcomes and reduced revision surgery rates when compared to L-FESS in CRSwNP patients two years after surgery, irrespective of any comorbidity. Further randomized prospective studies are needed to comprehensively contrast these results.
(1) 背景:伴鼻息肉的慢性鼻-鼻窦炎(CRSwNP)的手术标准仍未明确。本研究通过比较扩大功能性鼻内镜鼻窦手术(E-FESS)与更有限的鼻内镜鼻窦手术(L-FESS)的临床结局来解决这些差异。(2) 方法:对一个数据库进行回顾性分析,以比较接受E-FESS的CRSwNP患者与接受L-FESS的患者的手术结局。在基线和术后两年比较生活质量、内镜和影像学结局。当SNOT-22变化达到最小临床重要差异12分时,定义为有反应者的临床状态。(3) 结果:共有274例患者符合纳入标准并进行分析;111例行E-FESS,163例行L-FESS。两组均表现出显著的临床改善,尽管E-FESS术后SNOT-22的变化幅度更大(14.8±4.8,P = 0.002)。E-FESS组在内镜和影像学评分方面也有更高的显著改善,手术翻修率更低。(4) 结论:与L-FESS相比,CRSwNP患者术后两年行E-FESS可提供更好的临床结局并降低手术翻修率,无论有无合并症。需要进一步的随机前瞻性研究来全面对比这些结果。